Amgen, Inc. (AMGN)
443.84
+4.51
(+1.03%)
USD |
NASDAQ |
Aug 24, 16:00
444.00
+0.16
(+0.04%)
After-Hours: 20:00
Amgen Debt to Equity Ratio : 4.903 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.903 |
| March 31, 2026 | 6.238 |
| December 31, 2025 | 6.403 |
| September 30, 2025 | 5.675 |
| June 30, 2025 | 7.566 |
| March 31, 2025 | 9.245 |
| December 31, 2024 | 10.36 |
| September 30, 2024 | 8.024 |
| June 30, 2024 | 10.57 |
| March 31, 2024 | 12.75 |
| December 31, 2023 | 10.50 |
| September 30, 2023 | 7.898 |
| June 30, 2023 | 9.076 |
| March 31, 2023 | 11.52 |
| December 31, 2022 | 10.83 |
| September 30, 2022 | 10.60 |
| June 30, 2022 | 15.10 |
| March 31, 2022 | 40.23 |
| December 31, 2021 | 5.072 |
| September 30, 2021 | 4.573 |
| June 30, 2021 | 3.975 |
| March 31, 2021 | 3.502 |
| December 31, 2020 | 3.555 |
| September 30, 2020 | 3.129 |
| June 30, 2020 | 3.211 |
| Date | Value |
|---|---|
| March 31, 2020 | 3.358 |
| December 31, 2019 | 3.146 |
| September 30, 2019 | 2.771 |
| June 30, 2019 | 2.882 |
| March 31, 2019 | 3.094 |
| December 31, 2018 | 2.714 |
| September 30, 2018 | 2.399 |
| June 30, 2018 | 2.314 |
| March 31, 2018 | 2.275 |
| December 31, 2017 | 1.400 |
| September 30, 2017 | 1.110 |
| June 30, 2017 | 1.105 |
| March 31, 2017 | 1.113 |
| December 31, 2016 | 1.158 |
| September 30, 2016 | 1.148 |
| June 30, 2016 | 1.102 |
| March 31, 2016 | 1.196 |
| December 31, 2015 | 1.124 |
| September 30, 2015 | 1.136 |
| June 30, 2015 | 1.163 |
| March 31, 2015 | 1.145 |
| December 31, 2014 | 1.192 |
| September 30, 2014 | 1.302 |
| June 30, 2014 | 1.367 |
| March 31, 2014 | 1.408 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Gilead Sciences, Inc. | 2.219 |
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
| AbbVie, Inc. | -11.93 |
| Biogen, Inc. | 0.4433 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 95.64B |
| Total Liabilities (Quarterly) | 83.95B |
| Shareholders Equity (Quarterly) | 11.69B |
| Current Ratio | 1.371 |
| Net Debt Paydown Yield | 0.01% |